Amorphous form of cell cycle inhibitor

Details for Australian Patent Application No. 2002213965 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Shah, Navnit Hargovindas; Phuapradit, Wantanee; Albano, Antonio A.; Sandhu, Harpreet K.

Agent Davies Collison Cave

Pub. Number AU-B-2002213965

PCT Pub. Number WO02/28855

Priority 60/237,563 03.10.00 US

Filing date 26 September 2001

Wipo publication date 15 April 2002

Acceptance publication date 19 July 2007

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 July 2007 Application Accepted

  Published as AU-B-2002213965

15 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002213966

2002213964